Breast cancers can be categorized into three molecular subtypes based on expression of hormone receptors (HR), such as estrogen receptor (ER) or progesterone receptor (PR), and amplification/overexpression of the human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and breast carcinoma.